We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Stoke Therapeutics
STOK
$1.99B
| $156K | ﹤0.01% |
+13,832
| New | +$131K |
|
1552
Rocky Brands
RCKY
$374M
| $155K | ﹤0.01% |
+6,992
| New | +$133K |
|
1553
First Bank
FRBA
$468M
| $154K | ﹤0.01% |
+9,992
| New | +$145K |
|
1554
Nomad Foods
NOMD
$1.65B
| $154K | ﹤0.01% |
9,080
-178,436
| -95% | -$3.27M |
|
1555
Array Technologies
ARRY
$868M
| $153K | ﹤0.01% |
+26,034
| New | +$158K |
|
1556
PG&E
PCG
$37.9B
| $153K | ﹤0.01% |
11,000
-865
| -7% | -$14.1K |
|
1557
Occidental Petroleum
OXY
$53.5B
| $152K | ﹤0.01% |
3,642
-13,185
| -78% | -$551K |
|
|
BAND
1558
Bandwidth Inc
BAND
$1.47B
| $149K | ﹤0.01% |
9,432
-96,127
| -91% | -$1.31M |
|
1559
Phillips 66
PSX
$81.2B
| $149K | ﹤0.01% |
1,253
+80
| +7% | +$8.96K |
|
1560
LendingTree
TREE
$475M
| $149K | ﹤0.01% |
4,040
-511
| -11% | -$20.6K |
|
|
MMT
1561
Aberdeen Multi-Market Income Fund
MMT
$239M
| – | – |
0
| – | – |
|
1562
Graco
GGG
$13.4B
| $147K | ﹤0.01% |
1,720
+117
| +7% | +$9.7K |
|
1563
Academy Sports + Outdoors
ASO
$2.97B
| $146K | ﹤0.01% |
3,270
+360
| +12% | +$14.9K |
|
|
NFBK
1564
DELISTED
Northfield Bancorp
NFBK
| $146K | ﹤0.01% |
+12,776
| New | +$142K |
|
1565
Natera
NTRA
$39.3B
| $146K | ﹤0.01% |
868
+193
| +29% | +$30.1K |
|
1566
Amphastar Pharmaceuticals
AMPH
$892M
| $145K | ﹤0.01% |
+6,344
| New | +$157K |
|
1567
Canadian National Railway
CNI
$77.1B
| $145K | ﹤0.01% |
1,401
| – | – |
|
1568
Molina Healthcare
MOH
$10.2B
| $145K | ﹤0.01% |
489
+33
| +7% | +$10.4K |
|
|
WBA
1569
DELISTED
Walgreens Boots Alliance
WBA
| $145K | ﹤0.01% |
+12,691
| New | +$141K |
|
1570
Owens Corning
OC
$12.3B
| $144K | ﹤0.01% |
1,054
-341
| -24% | -$47.1K |
|
|
PRSU
1571
Pursuit Attractions and Hospitality Inc
PRSU
$1.38B
| $144K | ﹤0.01% |
5,056
-35
| -0.7% | -$1.03K |
|
|
IFLN
1572
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
| – | – |
0
| – | – |
|
|
1573
HEICO Corp Class A
HEI.A
$37.2B
| $142K | ﹤0.01% |
550
+50
| +10% | +$10.9K |
|
1574
Archer Aviation
ACHR
$3.97B
| $141K | ﹤0.01% |
13,107
-11,257
| -46% | -$105K |
|
|
CHCT
1575
Community Healthcare Trust
CHCT
$440M
| $141K | ﹤0.01% |
8,496
| – | – |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.